Vanguard Investments Australia
COLL icon

Vanguard Investments Australia’s Collegium Pharmaceutical COLL Stock Holding History

Vanguard Investments Australia’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Hold
7,472
– – ﹤0.01% 1974
2026
Q1 		$247K Buy
+7,472
New +$316K ﹤0.01% 1939

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Investments Australia's COLL Position: Q2 2026 in Review

Vanguard Investments Australia held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 7,472 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Vanguard Investments Australia first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Vanguard Investments Australia held 7,472 shares of Collegium Pharmaceutical worth $270K as of Q2 2026.
  • Vanguard Investments Australia left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1974 holding.
  • Vanguard Investments Australia first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.